Biotech · Private company
Surface Ophthalmics, Inc.
Track this companyFree. Adds Surface Ophthalmics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- 0.02% Betamethasone Sodium PhosphatePhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- 0.04% Betamethasone Sodium PhosphatePhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Betamethasone Sodium Phosphate 0.01%Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Cyclosporine 0.05% Ophthalmic EmulsionPhase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Mycophenolic Acid 0.1%Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Mycophenolic Acid 0.3%Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)Phase 2 · Dry Eye DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- SURF-201Phase 2 · Post-surgical Ocular InflammationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye DiseasePHASE2 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04734197 · fetched Nov 12, 2026
- Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye DiseasePHASE2 · COMPLETED · started Jan 7, 2021ClinicalTrials.gov NCT04734210 · fetched Nov 12, 2026
- Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery SubjectsPHASE2 · COMPLETED · started Mar 3, 2020ClinicalTrials.gov NCT04324359 · fetched Nov 12, 2026